1. Home
  2. LYEL vs ISD Comparison

LYEL vs ISD Comparison

Compare LYEL & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$21.13

Market Cap

490.1M

Sector

Health Care

ML Signal

HOLD

Logo PGIM High Yield Bond Fund Inc.

ISD

PGIM High Yield Bond Fund Inc.

HOLD

Current Price

$13.28

Market Cap

488.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYEL
ISD
Founded
2018
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
490.1M
488.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
LYEL
ISD
Price
$21.13
$13.28
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$27.25
N/A
AVG Volume (30 Days)
101.0K
99.2K
Earning Date
06-15-2026
01-01-0001
Dividend Yield
N/A
9.69%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$11.82
52 Week High
$45.00
$14.79

Technical Indicators

Market Signals
Indicator
LYEL
ISD
Relative Strength Index (RSI) 40.21 19.43
Support Level $15.82 N/A
Resistance Level $27.30 $14.67
Average True Range (ATR) 1.92 0.18
MACD -0.11 -0.12
Stochastic Oscillator 9.65 8.33

Price Performance

Historical Comparison
LYEL
ISD

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

About ISD PGIM High Yield Bond Fund Inc.

PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.

Share on Social Networks: